"Immunoglobulins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Multi-subunit proteins which function in IMMUNITY. They are produced by B LYMPHOCYTES from the IMMUNOGLOBULIN GENES. They are comprised of two heavy (IMMUNOGLOBULIN HEAVY CHAINS) and two light chains (IMMUNOGLOBULIN LIGHT CHAINS) with additional ancillary polypeptide chains depending on their isoforms. The variety of isoforms include monomeric or polymeric forms, and transmembrane forms (B-CELL ANTIGEN RECEPTORS) or secreted forms (ANTIBODIES). They are divided by the amino acid sequence of their heavy chains into five classes (IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M) and various subclasses.
Descriptor ID |
D007136
|
MeSH Number(s) |
D12.776.124.486.485 D12.776.124.790.651 D12.776.377.715.548
|
Concept/Terms |
Immunoglobulins- Immunoglobulins
- Immunoglobulin
- Globulins, Immune
- Immune Globulins
|
Below are MeSH descriptors whose meaning is more general than "Immunoglobulins".
Below are MeSH descriptors whose meaning is more specific than "Immunoglobulins".
This graph shows the total number of publications written about "Immunoglobulins" by people in this website by year, and whether "Immunoglobulins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 2 | 0 | 2 |
1995 | 0 | 3 | 3 |
1996 | 2 | 2 | 4 |
1997 | 2 | 1 | 3 |
1998 | 2 | 3 | 5 |
1999 | 0 | 1 | 1 |
2000 | 0 | 3 | 3 |
2001 | 4 | 3 | 7 |
2002 | 0 | 1 | 1 |
2003 | 0 | 3 | 3 |
2004 | 4 | 2 | 6 |
2005 | 2 | 3 | 5 |
2006 | 3 | 2 | 5 |
2007 | 2 | 4 | 6 |
2008 | 0 | 2 | 2 |
2009 | 1 | 5 | 6 |
2010 | 1 | 4 | 5 |
2011 | 2 | 2 | 4 |
2012 | 0 | 1 | 1 |
2013 | 3 | 1 | 4 |
2014 | 0 | 3 | 3 |
2015 | 4 | 2 | 6 |
2016 | 1 | 0 | 1 |
2017 | 2 | 1 | 3 |
2018 | 2 | 0 | 2 |
2019 | 2 | 5 | 7 |
2020 | 4 | 2 | 6 |
2021 | 0 | 1 | 1 |
2022 | 0 | 4 | 4 |
2023 | 1 | 5 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Immunoglobulins" by people in Profiles.
-
Tumor-Infiltrating Normal B Cells Revealed by Immunoglobulin Repertoire Clonotype Analysis Are Highly Prognostic and Crucial for Antitumor Immune Responses in DLBCL. Clin Cancer Res. 2023 12 01; 29(23):4808-4821.
-
Antibody neutralisation of emerging SARS-CoV-2 subvariants: EG.5.1 and XBC.1.6. Lancet Infect Dis. 2023 10; 23(10):e397-e398.
-
In-vivo and human evidence for potential efficacy of therapeutic polyclonal RSV neutralizing antibodies for palivizumab-resistant RSV infections. Virology. 2023 09; 586:115-121.
-
CancerHERVdb: Human Endogenous Retrovirus (HERV) Expression Database for Human Cancer Accelerates Studies of the Retrovirome and Predictions for HERV-Based Therapies. J Virol. 2023 06 29; 97(6):e0005923.
-
Prognostic impact of pretreatment immunoglobulin clonal composition in pediatric B-lymphoblastic leukemia. Haematologica. 2023 03 01; 108(3):900-904.
-
Glioma epileptiform activity and progression are driven by IGSF3-mediated potassium dysregulation. Neuron. 2023 03 01; 111(5):682-695.e9.
-
Clinical and In Vitro Evidence Favoring Immunoglobulin Treatment of a Chronic Norovirus Infection in a Patient With Common Variable Immunodeficiency. J Infect Dis. 2022 Nov 11; 226(10):1781-1789.
-
Resistance of SARS-CoV-2 omicron subvariant BA.4.6 to antibody neutralisation. Lancet Infect Dis. 2022 12; 22(12):1666-1668.
-
BETA PRIME: Phase I study of AdAPT-001 as monotherapy and combined with a checkpoint inhibitor in superficially accessible, treatment-refractory solid tumors. Future Oncol. 2022 Sep; 18(29):3245-3254.
-
Human immune globulin treatment controls Zika viremia in pregnant rhesus macaques. PLoS One. 2022; 17(7):e0266664.